Economy
Producer Price Index
U.S. Wholesale prices rose 0.1 % in November, led by growth in food, materials for manufacturing and crude petroleum prices.
|
Housing Starts
Housing starts continue to increase after recent decline, as construction of multi-family housing units as well as growing demand for single-family homes, helped to clinch a 1.1 % gain in November.
|
![Kitchen_stuff_By_Smoth_007_from_Christchurch_New_Zealand__[CC-BY-SA-2.0_(http_creativecommons.org_licenses_by-sa_2.0)]_via_Wikimedia_Commons](../news/img/durable_goods/Kitchen_stuff_By_Smoth_007_from_Christchurch_New_Zealand__[CC-BY-SA-2.0_(http_creativecommons.org_licenses_by-sa_2.0)]_via_Wikimedia_Commons.jpg "Kitchen_stuff_By_Smoth_007_from_Christchurch_New_Zealand__[CC-BY-SA-2.0_(http_creativecommons.org_licenses_by-sa_2.0)]_via_Wikimedia_Commons")
Durable Goods Orders
Durable Goods orders continued to grow, as bookings outgrow production.
|
|
Rasna Therapeutics Inc
Company reports $-2.29 million loss, as impairment charges strip off $2.27 million from the fourth quarter of 2020 results.
Rasna Therapeutics Inc reported operating deficit of $-5.005433 millions, in the fourth quarter of 2020, a deterioration from the operating loss of $-0.060707 millions, realized in fourth quarter of 2019
RASP stock quotes, charts, profile
Growth Rates, Profitability, PE
Ab International Group Corp
In the fiscal first quarter of 2020 Ab International Group Corp lost money of $-0.01 per share compared to $-0.01 a year ago and from $-0.00 per share from the previous quarter.
Sales fell sharply by -50.9% to $0.08 millions from $0.16 millions in the same quarter a year ago and sequentially Sales remained unchanged from $0.08 millions.
|
![Wells_Fargo_Center_at_Sunset_By_refractor_(Flickr)__[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Commons](../news/img/realestate/Wells_Fargo_Center_at_Sunset_By_refractor_(Flickr)__[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Commons.jpg "Wells_Fargo_Center_at_Sunset_By_refractor_(Flickr)__[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Commons")
Eaco Corp
In the first quarter of 2020 Eaco Corp earnings per share plummeted by -56.41% of $0.17 per share compared to $0.39 a year ago and profit plummeted by -45.05% from $0.31 per share from the previous quarter.
Sales contracted by -4.71% to $53.40 millions from $56.04 millions in the same quarter a year ago and sequentially Sales deteriorated by -7.05% from $57.45 millions.
|
|
Recently Reported Results |
|
Greystone Logistics Inc
Company reported strong income growth of 200 % to $0.03 per share, on fading Sales of -20.41% to $15.52 millions in the second quarter of 2020, compared to previous year.
In contrast to the first quarter Sales deteriorated by -11.64% from $17.57 millions and eps remained unchanged from $0.03 per share.
GLGI stock quotes, charts, profile
Growth Rates, Profitability, PE
|
|
Daybreak Oil and Gas Inc
Daybreak Oil And Gas Inc recorded operating deficit of $-0.095615 millions, in the fiscal third quarter of 2020, a degradation from the operating loss of $-0.072688 millions, reported in third quarter of 2019
Sales faded by -32.15% to $0.10 millions from $0.14 millions in the same quarter a year ago and sequentially Sales deteriorated by -11.28% from $0.11 millions.
DBRM stock quotes, charts, profile
Growth Rates, Profitability, PE
|
|
Oramed Pharmaceuticals Inc
In the financial first quarter of 2020 Oramed Pharmaceuticals Inc earnings jumped by 53.33 % of $0.23 per share compared to $0.15 a year ago and eps soared by 81.35 % from $0.13 per share from the previous quarter.
Sales remained unchanged by 0% to $0.67 millions from $0.67 millions in the same quarter a year ago and sequentially Sales decreased by -1.03% from $0.68 millions.
ORMP stock quotes, charts, profile
Growth Rates, Profitability, PE
|
![Mikroprozessor_By_Elmar_Ersch_(Own_work)__[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Common](../news/img/semiconductors/Mikroprozessor_By_Elmar_Ersch_(Own_work)__[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Common.jpg "Mikroprozessor_By_Elmar_Ersch_(Own_work)__[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Common")
Semileds Corp
Semileds Corp reported disastrous first quarter of 2020, where Sales faded by -54% to $0.72 millions and loss per share has widen to $-0.17, from the same quarter a year ago.
Eps soared from the preceding quarter from $-0.01 per share, Sales Tumbled by -48.61% from $1.40 millions.
LEDS stock quotes, charts, profile
Growth Rates, Profitability, PE
|
Limoneira Company
In the fourth quarter of 2020 earnings season Limoneira Company increased losses of $-0.42 per share compared to $-0.18 a year ago and eps fell from $0.12 per share from the previous quarter.
Sales declined in double digits by -18.38% to $29.77 millions from $36.48 millions in the same quarter a year ago and sequentially Sales Tumbled by -44.41% from $53.56 millions.
LMNR stock quotes, charts, profile
Growth Rates, Profitability, PE
|
![Autosample_takes_a_By_Hey_Paul_(originally_posted_to_Flickr_as_image8)_[CC-BY-SA-2.0_(http_creativecommons.org_licenses_by-sa_2.0)]_via_Wikimedia_Commons](../news/img/healthcare/Autosample_takes_a_By_Hey_Paul_(originally_posted_to_Flickr_as_image8)_[CC-BY-SA-2.0_(http_creativecommons.org_licenses_by-sa_2.0)]_via_Wikimedia_Commons.jpg "Autosample_takes_a_By_Hey_Paul_(originally_posted_to_Flickr_as_image8)_[CC-BY-SA-2.0_(http_creativecommons.org_licenses_by-sa_2.0)]_via_Wikimedia_Commons")
Cannabics Pharmaceuticals Inc
In the financial first quarter of 2020 Cannabics Pharmaceuticals Inc loss increased of $-0.01 per share compared to $0.04 a year ago and improved from $-0.08 per share from the previous quarter.
Sales remained unchanged to $0.00 millions from $0.00 millions in the same quarter a year ago and sequentially from $0.00 millions.
CNBK stock quotes, charts, profile
Growth Rates, Profitability, PE
|
|
|
|
Recently Reported Results |
![Autosample_takes_a_By_Hey_Paul_(originally_posted_to_Flickr_as_image4)_[CC-BY-SA-2.0_(http_creativecommons.org_licenses_by-sa_2.0)]_via_Wikimedia_Commons](../news/img/healthcare/Autosample_takes_a_By_Hey_Paul_(originally_posted_to_Flickr_as_image4)_[CC-BY-SA-2.0_(http_creativecommons.org_licenses_by-sa_2.0)]_via_Wikimedia_Commons.jpg "Autosample_takes_a_By_Hey_Paul_(originally_posted_to_Flickr_as_image4)_[CC-BY-SA-2.0_(http_creativecommons.org_licenses_by-sa_2.0)]_via_Wikimedia_Commons")
Rasna Therapeutics Inc
Company reports $-2.29 million loss, as impairment charges strip off $2.27 million from the most recent fiscal period results.
Rasna Therapeutics Inc reported operating loss of $-5.005433 millions, in the most recent fiscal period, a deterioration from the operating shortfall of $-0.060707 millions, realized in fourth quarter of 2019
RASP stock quotes, charts, profile
Growth Rates, Profitability, PE
|
Housing Starts
Housing starts continue to increase after recent decline, as construction of multi-family housing units as well as growing demand for single-family homes, helped to clinch a 1.1 % gain in November.
|
![Annual_Reception__[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Common](../news/img/services/Annual_Reception__[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Common.jpg "Annual_Reception__[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Common")
Volt Information Sciences Inc
In the fourth quarter of 2020 Volt Information Sciences Inc increased losses of $-0.58 per share compared to $-0.04 a year ago and increased losses from $-0.22 per share from the previous quarter.
Sales declined in double digits by -18.32% to $211.07 millions from $258.41 millions in the same quarter a year ago and sequentially Sales advanced by 13.52 % from $185.94 millions.
VOLT stock quotes, charts, profile
Growth Rates, Profitability, PE
|
![Integrated_circuits_By_T137_(Own_work)__[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Common](../news/img/semiconductors/Integrated_circuits_By_T137_(Own_work)__[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Common.jpg "Integrated_circuits_By_T137_(Own_work)__[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Common")
Aehr Test Systems
Aehr Test Systems reported disastrous financial second quarter of 2020, where Sales faded by -75.52% to $1.68 millions and loss per share has widen at $-0.08, from the same quarter a year ago.
increased from the preceding quarter from $0.00 per share, Sales fell by -16.35% from $2.01 millions.
AEHR stock quotes, charts, profile
Growth Rates, Profitability, PE
|
Greystone Logistics Inc
Company reported strong income growth of 200 % to $0.03 per share, on fading Sales of -20.41% to $15.52 millions in the second quarter of 2020 earnings season, compared to previous year.
In contrast to the first quarter Sales deteriorated by -11.64% from $17.57 millions and eps remained unchanged from $0.03 per share.
GLGI stock quotes, charts, profile
Growth Rates, Profitability, PE
|
|
Durable Goods Orders
Durable Goods orders continued to grow, as bookings outgrow production.
|
Gross Domestic Product
The third and final government estimate of third-quarter GDP, shows that the nations output has accelerated in the third-quarter, as consumer spending, investments and exports play major role in the advance.
|
Industrial production
The output of the nation's factories, mines and utilities continues to grow but on the slower pace, mainly because of declinig output at utilities.
|
Daybreak Oil and Gas Inc
Daybreak Oil And Gas Inc recorded operating deficit of $-0.095615 millions, in the most recent fiscal period, a degradation from the operating loss of $-0.072688 millions, reported in third quarter of 2019
Sales faded by -32.15% to $0.10 millions from $0.14 millions in the same quarter a year ago and sequentially Sales deteriorated by -11.28% from $0.11 millions.
DBRM stock quotes, charts, profile
Growth Rates, Profitability, PE
|
|
Oramed Pharmaceuticals Inc
In the fiscal period ending Nov 30 2020 Oramed Pharmaceuticals Inc earnings jumped by 53.33 % of $0.23 per share compared to $0.15 a year ago and eps soared by 81.35 % from $0.13 per share from the previous quarter.
Sales remained unchanged by 0% to $0.67 millions from $0.67 millions in the same quarter a year ago and sequentially Sales decreased by -1.03% from $0.68 millions.
ORMP stock quotes, charts, profile
Growth Rates, Profitability, PE
|
![TSF2_By_TSFgrupo1_(Own_work)__[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Common](../news/img/semiconductors/TSF2_By_TSFgrupo1_(Own_work)__[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Common.jpg "TSF2_By_TSFgrupo1_(Own_work)__[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Common")
Semileds Corp
Semileds Corp reported disastrous financial period ending Nov 30 2020, where Sales faded by -54% to $0.72 millions and loss per share has widen to $-0.17, from the same quarter a year ago.
Eps soared from the preceding quarter from $-0.01 per share, Sales Tumbled by -48.61% from $1.40 millions.
LEDS stock quotes, charts, profile
Growth Rates, Profitability, PE
|
|
Limoneira Company
In the most recent fiscal period Limoneira Company increased losses of $-0.42 per share compared to $-0.18 a year ago and eps fell from $0.12 per share from the previous quarter.
Sales declined in double digits by -18.38% to $29.77 millions from $36.48 millions in the same quarter a year ago and sequentially Sales Tumbled by -44.41% from $53.56 millions.
LMNR stock quotes, charts, profile
Growth Rates, Profitability, PE
|
![pills2_By_Tom_Varco_(Own_work)_[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Commons](../news/img/healthcare/pills2_By_Tom_Varco_(Own_work)_[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Commons.jpg "pills2_By_Tom_Varco_(Own_work)_[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Commons")
Cannabics Pharmaceuticals Inc
In the fiscal first quarter of 2020 Cannabics Pharmaceuticals Inc loss increased of $-0.01 per share compared to $0.04 a year ago and improved from $-0.08 per share from the previous quarter.
Sales remained unchanged to $0.00 millions from $0.00 millions in the same quarter a year ago and sequentially from $0.00 millions.
CNBK stock quotes, charts, profile
Growth Rates, Profitability, PE
|
Lexaria Bioscience Corp
Lexaria Bioscience Corp announced very strong Sales growth of 379.08% year on year to $0.30 millions in the financial time frame ending Nov 30 2020, but increased losses at $-0.24.
compared to previous quarter increased losses from $-0.01 per share and Sales doubled by 122.39 % from $0.13 millions.
LXRP stock quotes, charts, profile
Growth Rates, Profitability, PE
|
|
|
|
|
Tweet
